Growth in its imaging and therapy systems businesses boosted Siemens Healthcare's revenues in the second quarter of fiscal 2012 (end-March 31).
Second-quarter healthcare revenues increased 8% to 3.36 billion euros ($4.44 billion U.S.), compared with 3.12 billion euros ($4.12 billion) in the second quarter of fiscal 2011. Profit decreased to a total of 424 million euros ($560 million), compared with 450 million euros ($595 million) in the second quarter of the previous fiscal year.
Siemens attributed the profit decrease to charges of 38 million euros ($50 million) related to its Healthcare Agenda 2012 initiative; the company's Diagnostics unit accounted for 20 million euros ($26 million) of these charges.
On a regional basis, Asia and Australia posted double-digit increases in both revenue and orders, highlighted by substantial growth in China.
For the six-month period, revenues increased to 6.51 billion euros ($8.6 billion), compared with 6.25 billion euros ($8.26 billion) in the same period of fiscal 2011. Profit slipped to 788 million euros ($1 billion), compared with 832 million euros ($1.1 billion) in the first half of fiscal 2011.
